Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. The role of the Heart Team in the planning of aortic valve replacement

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Will the Evolut Low Risk trial change my practice?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Durability of transcatheter bioprosthetic aortic valves: the story so far

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The EuroIntervention health check 2019

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Alaide Chieffo
  • Gill Louise Buchanan
  • Julinda Mehilli
  • Davide Capodanno
  • Vijay Kunadian
  • Anna Sonia Petronio
  • Ghada W Mikhail
  • Piera Capranzano
  • Nieves Gonzal
  • Nicole Karam
  • Stéphane Manzo-Silberman
  • Stefanie Schüpke
  • Robert A Byrne
  • Giuliana Capretti
  • Yolande Appelman
  • Marie-Claude Morice
  • Patrizia Presbitero
  • Maria Radu
  • Josepa Mauri
Vis graf over relationer

Several expert documents on sex-based differences in interventional outcomes are now available, however this is the first position paper from the EAPCI Women Committee discussing the potential influence of sex in the percutaneous treatment of coronary and structural heart disease. Despite the misconception that coronary artery disease is a 'man's disease', contemporary data shows a growing incidence in women. However, women are under-represented in randomised coronary clinical trials (~25%). The generalisation of such studies is therefore problematic in decision-making for females undergoing coronary intervention. Differences in pathophysiology between sexes exist, highlighting the need for greater awareness amongst healthcare professionals to enable best evidence-based therapies for women as well as for men. Reassuringly, women represent half of the population included in transcatheter aortic valve implantation clinical trials and may actually benefit more. Growing evidence is also emerging for other interventional atrial procedures which may well be advantageous to women. Awareness of sex disparities is increasing, and we must all work collaboratively within our profession to ensure we provide effective care for all patients with heart disease. The EAPCI Women Committee aim to highlight such issues through this position paper and through visibility within the interventional community.

OriginalsprogEngelsk
TidsskriftEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Vol/bind14
Udgave nummer11
Sider (fra-til)e1227-e1235
ISSN1774-024X
DOI
StatusUdgivet - 7 dec. 2018

ID: 56526408